Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Inventory (2016 - 2023)

Lexaria Bioscience's Inventory history spans 9 years, with the latest figure at $7588.0 for Q1 2023.

  • For Q1 2023, Inventory fell 76.23% year-over-year to $7588.0; the TTM value through Feb 2023 reached $7588.0, down 76.23%, while the annual FY2022 figure was $38418.0, 29.58% up from the prior year.
  • Inventory for Q1 2023 was $7588.0 at Lexaria Bioscience, down from $9936.0 in the prior quarter.
  • Across five years, Inventory topped out at $188275.0 in Q2 2019 and bottomed at -$6067.0 in Q4 2020.
  • The 5-year median for Inventory is $51738.0 (2021), against an average of $76415.9.
  • The largest annual shift saw Inventory plummeted 104.54% in 2020 before it skyrocketed 544.47% in 2021.
  • A 5-year view of Inventory shows it stood at $133556.0 in 2019, then tumbled by 104.54% to -$6067.0 in 2020, then surged by 544.47% to $26966.0 in 2021, then crashed by 63.15% to $9936.0 in 2022, then dropped by 23.63% to $7588.0 in 2023.
  • Per Business Quant, the three most recent readings for LEXX's Inventory are $7588.0 (Q1 2023), $9936.0 (Q4 2022), and $38418.0 (Q3 2022).